EUVIMEDEUVIMED entdecken
Crossref

Impact of 5-ALA and sodium fluorescein on FLAIR volume extent of resection and survival in IDH-wildtype glioblastoma

Castaldo Margherita, Zeppa Pietro, Bianconi Andrea iD, Bradaschia Leonardo, Dolci Lorenzo, Bruno Francesco, Antonio Melcarne, Morana Giovanni, Rudà Roberta, Garbossa Diego, Cofano Fabio

Journal of Neuro-Oncology · 2026

DOI: 10.1007/s11060-026-05802-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2026. Verfasst von Castaldo Margherita und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgery Unit, Department of Neuroscience, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Glioblastoma, Aminolevulinic Acid, Fluorescein, Magnetic Resonance Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to determine whether the choice of fluorophore (5-aminolevulinic acid [5-ALA], sodium fluorescein [SF], or their combination) influences the extent of resection (EOR) of FLAIR-hyperintense regions and, consequently, patient survival in IDH-wildtype glioblastoma.

Methods

This single-center retrospective study included 154 adult patients who underwent surgical resection of supratentorial glioblastoma between January 2021 and January 2023. Patients received 5-ALA ( n = 63), SF ( n = 69), or both ( n = 22), depending on institutional drug availability over the study period. Volumetric analysis was performed using semi-automated segmentation on preoperative and early postoperative MRI. EOR was calculated separately for contrast-enhancing (CE) and FLAIR components. Survival outcomes were assessed using Kaplan-Meier and Cox proportional hazards analyses.

Results

No statistically significant differences were observed between fluorophore groups regarding EOR-CE ( p = 0.298), EOR-FLAIR ( p = 0.060), or EOR-total ( p = 0.293). However, 5-ALA use was associated with significantly improved progression-free survival (median 8.5 vs. 6.0 months; HR 1.89, 95% CI 1.26–2.81, p = 0.002) and overall survival (median 17.0 vs. 11.0 months; HR 2.32, 95% CI 1.33–4.04, p = 0.003) compared with SF. The survival advantage remained significant after adjustment for age, KPS, MGMT status, and adjuvant treatment ( p < 0.05).

Conclusion

While no significant differences in FLAIR volume resection were observed between fluorophores, 5-ALA was associated with longer PFS and OS. The association persisted in multivariable models adjusting for residual tumor volumes, continuous EOR and RANO resect category. This may reflect a more biologically selective resection within the FLAIR-hyperintense region, a hypothesis that remains to be tested prospectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaAminolevulinic AcidFluoresceinMagnetic Resonance ImagingBrain NeoplasmsNeurosurgical ProceduresHumansFemaleMaleRetrospective StudiesMiddle AgedAgedAdultIsocitrate DehydrogenaseFollow-Up StudiesFluorescent DyesSurvival RatePrognosis

Stichwörter der Autor:innen

5-aminolevulinic acidExtent of resectionFluorescence-guided surgeryGlioblastomaSodium fluoresceinSurvival

Substanzen

Aminolevulinic AcidFluoresceinIsocitrate DehydrogenaseFluorescent Dyes

Autor:innen und Institutionen

  • Neurosurgery Unit, Department of Neuroscience, University of Turin, Turin, Italy.
  • Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genova, Largo Paolo Daneo 3, 16132, Genova, Italy. andrea.bianconi@unige.it.
  • Neurosurgery Unit, IRCCS AOM Liguria, 16132, Genova, Italy. andrea.bianconi@unige.it.
  • Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy.
  • Division of Neuroradiology, Department of Diagnostic Imaging and Radiotherapy, "Città della Salute e della Scienza" University Hospital, University of Turin, 10124, Turin, Italy.

ORCID-Profile: Bianconi Andrea

Zitieren

APA

Margherita, C., Pietro, Z., Andrea, B., Leonardo, B., Lorenzo, D., Francesco, B., Melcarne, A., Giovanni, M., Roberta, R., Diego, G., & Fabio, C. (2026). Impact of 5-ALA and sodium fluorescein on FLAIR volume extent of resection and survival in IDH-wildtype glioblastoma. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-026-05802-1

Vancouver

Margherita C, Pietro Z, Andrea B, Leonardo B, Lorenzo D, Francesco B, et al. Impact of 5-ALA and sodium fluorescein on FLAIR volume extent of resection and survival in IDH-wildtype glioblastoma. Journal of Neuro-Oncology. 2026. doi:10.1007/s11060-026-05802-1

BibTeX
@article{Margherita2026,
  author = {Margherita, Castaldo and Pietro, Zeppa and Andrea, Bianconi and Leonardo, Bradaschia and Lorenzo, Dolci and Francesco, Bruno and Melcarne, Antonio and Giovanni, Morana and Roberta, Rudà and Diego, Garbossa and Fabio, Cofano},
  title = {Impact of 5-ALA and sodium fluorescein on FLAIR volume extent of resection and survival in IDH-wildtype glioblastoma},
  journal = {Journal of Neuro-Oncology},
  year = {2026},
  doi = {10.1007/s11060-026-05802-1}
}
Kostenlos starten →